Cytokinetics, Incorporated (CYTK) Net income 2016–2025
Cytokinetics, Incorporated (CYTK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$785.0MFY2025 · since FY2016: $16.5M → -$785.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$785.0M | -33.2% |
| FY2024 | -$589.5M | -12.0% |
| FY2023 | -$526.2M | -35.3% |
| FY2022 | -$389.0M | -80.6% |
| FY2021 | -$215.3M | -69.2% |
| FY2020 | -$127.3M | -4.6% |
| FY2019 | -$121.7M | -14.5% |
| FY2018 | -$106.3M | +16.8% |
| FY2017 | -$127.8M | -876.7% |
| FY2016 | $16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice